Genomic Health Announces Favorable Draft Local Coverage Determination from Palmetto GBA on Medicare Coverage for the Oncotype DX Prostate Cancer Test

By: via Benzinga
Genomic Health, Inc. (Nasdaq: GHDX) today announced that Palmetto GBA, a Medicare Administrative Contractor (MAC) that assesses ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.